Truvestments Capital LLC Invests $26,000 in CME Group Inc. (NASDAQ:CME)

Truvestments Capital LLC acquired a new stake in CME Group Inc. (NASDAQ:CMEFree Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 117 shares of the financial services provider’s stock, valued at approximately $26,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Ameriprise Financial Inc. lifted its position in shares of CME Group by 11.3% in the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after buying an additional 537,758 shares during the last quarter. Raymond James & Associates lifted its holdings in CME Group by 3.2% in the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock worth $595,530,000 after acquiring an additional 94,302 shares during the last quarter. Legal & General Group Plc lifted its holdings in CME Group by 6.6% in the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after acquiring an additional 176,004 shares during the last quarter. PineStone Asset Management Inc. boosted its stake in CME Group by 137.6% in the second quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock valued at $444,443,000 after acquiring an additional 1,309,097 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of CME Group by 1.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,981,961 shares of the financial services provider’s stock valued at $437,320,000 after purchasing an additional 26,642 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Ratings Changes

CME has been the subject of a number of analyst reports. Morgan Stanley boosted their price objective on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. Barclays boosted their price target on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Bank of America increased their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 target price on shares of CME Group in a research note on Thursday, October 24th. Finally, Piper Sandler raised their price target on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $224.47.

Read Our Latest Report on CME Group

CME Group Price Performance

CME stock opened at $237.33 on Friday. CME Group Inc. has a one year low of $190.70 and a one year high of $238.12. The firm has a 50-day moving average of $225.05 and a two-hundred day moving average of $211.73. The firm has a market capitalization of $85.52 billion, a PE ratio of 24.96, a P/E/G ratio of 5.29 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.25 EPS. On average, analysts forecast that CME Group Inc. will post 10.22 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a yield of 1.94%. CME Group’s payout ratio is presently 48.37%.

Insider Activity

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The trade was a 5.38 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Sunil Cutinho sold 4,500 shares of the firm’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the sale, the insider now directly owns 27,053 shares of the company’s stock, valued at $6,131,291.92. This trade represents a 14.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,028 shares of company stock worth $1,811,681 in the last 90 days. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.